Translational Research for cobinational chemotherapy with tumor microcirculation promotional agent in patients with advanced non-small cell lung cancer

肿瘤微循环促进剂联合化疗治疗晚期非小细胞肺癌的转化研究

• 批准号: 23591133
• 负责人: YASUDA Hiroyasu
• 金额: $ 3.33万
• 依托单位: Tohoku University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (C)
• 财政年份: 2011
• 资助国家: 日本
• 起止时间: 2011 至 2013
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23591133/
• 关键词: 一酸化窒素供与剤; 抗癌剤感受性; 腫瘍直接浸潤; 低酸素誘導因子; 腫瘍組織内低酸素状態; 無作為化比較試験; ニトログリセリン; 非小細胞肺癌; 一酸化窒素; 腫瘍循環; 化学療法感受性; アムルビシン; ゲムシタビン; 腫瘍縮小効果; がん細胞; ペメトレキセド; RFC-1; FPGS; 抗癌剤感受性増強効果; 臨床試験

Nitoroglycerin (NTG), nitric oxide donating agent (NDA), significantly reduced distribution of hypoxic area in solid cancer tissue in tumor bearing model mice. We made tumor bearing model mice with murine adenocarcinoma LLC cells and performed chemotherapy with them. Tumor growth curve was significantly inhibited in the group treated with pemetrexed and NTG compared with the group treated with pemetrexed alone.Multicenter-phase II trial of 3rd line chemotherapy with amrubicin with NTG patch in patients with stage IIIB and IV non-small cell lung cancer was performed in Kyoto Univ., Tohoku Univ., Shinshu Univ., and Juntendo Univ. Now the data analysis has been performed, and will be published.

Notoroglycerin（NTG），一氧化氮捐赠剂（NDA），在肿瘤轴承模型小鼠的固体癌组织中低氧区域的分布显着降低。我们用鼠腺癌LLC细胞制作了肿瘤轴承模型小鼠，并与它们进行了化学疗法。与单独用pemetrexede的组相比，用刺皮和NTG治疗的组对肿瘤生长曲线显着抑制。在患有IIIB和IIIB和IV非小细胞肺癌的患者中，使用Amrubicin用NTG贴剂进行Amrubicin对Amrubicin进行了amrubicin a amrubicin py Amrubicin pys amrubicin pys in kyoto和kyotiv shun kyuk univ。 Juntendo Univ。现在已经执行了数据分析，并将发布。

项目成果

進行非小細胞肺癌に対するGTN+/-CBDCA・TXL化学療法の無作為化比較試験

GTN+/-CBDCA/TXL化疗治疗晚期非小细胞肺癌的随机对照试验

A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD

• DOI: 10.1177/1753465810392264
• 发表时间: 2011-02
• 期刊: Therapeutic Advances in Respiratory Disease
• 影响因子: 4.3
• 作者: Takahiko Sasaki;K. Nakayama;H. Yasuda;M. Yamaya

Safty of erlotinib treatment in outpatients with previously treated non-small-cell lung cancer in Japan

日本既往接受过治疗的非小细胞肺癌门诊患者接受厄洛替尼治疗的安全性

• 发表时间: 2011
• 期刊: Int J Clin Oncol
• 影响因子: 3.3
• 作者: Nagai H;Tanaka S;Niimi M;et al.
• 通讯作者: et al.

Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double blind randomized crossover study.

使用葡萄糖溶液缓解吉西他滨引起的血管疼痛：双盲随机交叉研究。

• DOI: 10.1007/s00520-013-1901-9
• 发表时间: 2013
• 期刊: Support Care Cancer
• 影响因子: 3.1
• 作者: Nagai H;Kitano T;Nishimura T;Yasuda H;Nakata K;Takashima S;Kanai M;Matsumoto S;Mori Y;Kakudo Y;Sato H;Yamaguchi T;Kameno K;Kim YH;Mishima M;Yanagihara K.
• 通讯作者: Yanagihara K.

L-carbocisteine inhibits respiratory syncytial virus infection in human tracheal epithelial cells

• DOI: 10.1016/j.resp.2011.10.017
• 发表时间: 2012-01-15
• 期刊: RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
• 影响因子: 2.3
• 作者: Asada, Masanori;Yoshida, Motoki;Yamaya, Mutsuo
• 通讯作者: Yamaya, Mutsuo